Insight Molecular Diagnostics (IMDX) FCF Margin (2020 - 2026)
Insight Molecular Diagnostics (IMDX) posted FCF Margin of 25787.5% for Q1 2026, down 4081.66% sequentially from 616.68% in Q4 2025, and down 2550004.0% YoY from N/an in Q1 2025.
Insight Molecular Diagnostics (IMDX) FCF Margin (2020 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 7 years of FCF Margin data on file, last reported at 25787.5% in Q1 2026.
- Quarterly FCF Margin fell 2550004.0% year-over-year to 25787.5% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1409.7% (down 79827.0% YoY) and the FY2025 annual result came in at 625.62%, up 50170.0% from the prior year.
- FCF Margin retreated to 25787.5% in Q1 2026 per IMDX's latest filing, from 616.68% in the prior quarter.
- The five-year high for FCF Margin was 287.46% in Q1 2025, with the low at 25787.5% in Q1 2026.
- Average FCF Margin over 5 years is 4778.11%, with a median of 2189.77% recorded in 2024.
- Year-over-year, FCF Margin surged 1754396 bps in 2023 and sank 2550004 bps in 2026.
- Insight Molecular Diagnostics' FCF Margin stood at 3813.87% in 2022, then jumped by 61 bps to 1492.99% in 2023, then soared by 75 bps to 374.5% in 2024, then tumbled by 65 bps to 616.68% in 2025, then tumbled by 4082 bps to 25787.5% in 2026.
- Business Quant data shows IMDX's FCF Margin at 25787.5% in Q1 2026, 616.68% in Q4 2025, and 2135.38% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -3.31% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 7.41% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 18.23% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 22.61% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 2.59% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 10.95% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 11.83% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 23.01% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 12.92% |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | -25,787.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25,787.50% |
| Dec 31, 2025 | -616.68% |
| Sep 30, 2025 | -2,135.38% |
| Jun 30, 2025 | -1,283.20% |
| Mar 31, 2025 | -287.46% |
| Dec 31, 2024 | -374.50% |
| Sep 30, 2024 | -4,884.35% |
| Jun 30, 2024 | -5,931.73% |
| Mar 31, 2024 | -2,189.77% |
| Dec 31, 2023 | -1,492.99% |
| Sep 30, 2023 | -747.09% |
| Jun 30, 2023 | -1,475.59% |
| Mar 31, 2023 | -2,794.61% |
| Dec 31, 2022 | -3,813.87% |
| Sep 30, 2022 | -18,291.04% |
| Jun 30, 2022 | -5,217.30% |
| Mar 31, 2022 | -3,904.74% |
| Dec 31, 2021 | -208.02% |
| Sep 30, 2021 | -1,156.20% |
| Jun 30, 2021 | -427.00% |